large inocula of Newcastle disease virus (NDV) described by Ginsberg (1951) and by Davenport (1952) . Curiously, this preparation failed (a) to inactivate these viruses in vitro, (b) to affect viral synthesis in mouse lung tissue or in the allantoic cavity of eggs, or (c) to neutralize in vitro the toxicity of Newcastle disease virus for mouse lung tissue. Thus, it appeared that this substance selectively inhibited the development of the lesion. The absence of demonstrable antimicrobial or antiviral activity of this microbial product precludes its designation as an antibiotic according to the classical definition (Waksman, 1948 ). This preparation, provisionally designated APM (acid precipitable material), has here been named "xerosin".
Some of the properties of xerosin, its modifying effect on certain viral lesions, and a description of Achromobacter xerosis, n. sp., which produces xerosin are presented in this paper.
MATERLALS AN METHODS General. The following viruses were used throughout these studies: The PR-8 strain of influenza A virus, the Lee strain of influenza B virus, and the mouse adapted Nigg strain of mouse pneumonitis virus (Miyagawanella broncho-I This investigation was supported in part by a research grant (E-515) from the National Microbiological Institute of the National Institutes of Health, Public Health Service, and a research grant from the Rutgers Research and Endowment Foundation. 10 pneumoniae). All infectivity titrations of the influenza viruses were carried out in embryonated eggs as previously described (Group4 et al., 1951) , and 0.5 ml amounts of serial decimal dilutions of the tissue or fluid were injected into groups of 6 eggs each by the allantoic route. After 48 hours of incubation at 36 C the allantoic fluids were collected individually and were tested for the presence or absence of viral hemagglutinin using the pattern test (Salk, 1948) . When suspensions of mouse lung tissue were inoculated into eggs, the diluent for homogenized tissue contained 500 units each of penicillin and streptomycin to insure bacterial sterility. All infectivity titrations of mouse pneumonitis virus were carried out in mice in the usual manner, and 0.05 ml amounts of serial decimal dilutions of mouse lung tissue were instilled intranasally into groups of 5 or 6 mice each. All mice were sacrificed on the tenth day after infection, and the degree of pneumonia in each mouse was recorded.
Inoculaion and injection of mice. Infection of 18 to 20 g albino mice with influenza B virus or mouse pneumonitis virus was carried out in the usual manner. Mice under light ether anesthesia were instilled intranasally with 0.05 ml each of appropriately diluted virus. Xerosin, in aqueous solution, was injected subcutaneously under the loose skin on the backs of the mice unless otherwise noted. All cages were previously marked as control or as mice to be injected with xerosin and with the scheduled dates of injection, sacrifice, and examination. Appropriate numbers of mice previously infected with aliquots of the same inoculum then were distributed at random among the various cages. The lungs of each mouse were examined carefully, and the lesion score (see table 1) as described by Horsfall (1939) was recorded. The average weight of the lungs (e.g., weight of petri dish plus 10 lungs less weight of same dish after removal of lungs, divided by 10) of the various groups of mice also was determined.
The methods employed in all experiments concerned with the toxicity of influenza A virus for 11 to 14 g mice when injected by the intracerebral or intravenous routes were identical with those described by Henle and Henle (1946a,b) .
Description of Achromobacter xerosis, n. sp.2 The methods used in these studies were similar to those described by Gordon and Smith (1949 I/T = number mice infected/total. %L/M = total lesion score +. total maximum score X 100 (e.g., 10 mice each with a score of 2 = 20a s50 X 100 = 40% L/M).
Lesion score: X = <5% lung tissue consolidated; 1+ = 5-25%; 2+ = 26-50%; 3+ = 51-75%; 4+ = 76-100%; 5+ = dead mouse with consolidated lungs.
and litmus was reduced after 7 days of incubation. Nitrite was produced from nitrate. Starch was hydrolyzed. Gelatin was liquefied. Indole was not produced. Citrate was utilized as the sole source of carbon. Some hydrogen sulfide was produced after 7 days of incubation. Growth on potato was yellowish to brownish and appeared dry and wrinkled. Oxygen requirements. The culture was aerobic and failed to grow in the absence of gaseous oxygen. Source. The culture was isolated from soil.
Cultures on agar slants of Achromobacter xerosis were found to lose their viability after 7 to 21 days of storage in the refrigerator, but frequently transferred broth cultures were stable at refrigerator temperatures and produced xerosin satisfactorily. It was convenient to prepare inoculum pools from actively growing cultures to which sterile inactivated normal horse serum was added to make 20 per cent by volume before distribution into suitable vials. The vials were stored at -70 C until used. Frozen inocula were employed as a convenience and to avoid possible variation or lysogenicity in the culture. Lysogenicity has not been observed.
Preparation of xerosin. The method of preparation of xerosin was identical with that previously described (Group6 et al., 1952 A preparation was considered to be of satisfactory potency when the lesion score was reduced to X& or less that of the control, or the average weight of the lungs was at least 40 mg less than that of the control, or both. Of 50 different preparations tested, the lesion scores were reduced from M to M that of the control, and the average weights of the lungs were 30 to 80 mg less than that of the control.
Properties of xerosin. Previous studies (Groupe et al., 1952) have shown that the potency of aqueous solutions of xerosin was not completely destroyed by (a) exposure to a temperature of 120 C at pH 9 for 45 minutes; (b) dialysis against running tap water for 24 hours; (c) serial extraction of the same aqueous solution of xerosin with n-butanol, anesthetic ether, chloroform, petroleum ether, ethyl acetate, and benzene. In addition, half saturation of an aqueous solution of xerosin with ammonium sulfate resulted in the immediate formation of a flocculent precipitate which was both acid precipitable and potent.
Samples of representative preparations of xerosin were subjected to various color tests with the following results: Both the biuret and anthrone tests were positive, but Fehling's, Molisch, Millon's, nitroprusside, ninhydrin, and iodine tests were essentially negative. Analysis of 7 typical preparations of xerosin gave values that ranged from 9.7 to 12.1 per cent nitrogen (micro-Kjeldahl) and from 2.1 to 2.7 per cent phosphorus (method of Fiske and Subbarow).' The ultraviolet absorption spectrum of an aqueous solution of xerosin containing 0.05 mg per ml (figure 1) showed that the peak of absorption occurred between 255 and 260 m,u. Chemical studies were discontinued until preparations of greater purity become available. Acute toxicity tests in which serial twofold dilutions of xerosin were injected into groups of 6 mice weighing 10 to 12 g each indicated that the maximum tolerated dose (LDo) That xerosin was not virucidal for mouse pneumonitis virus was shown in the following experiment. Two ml of an aqueous solution of xerosin containing 6 mg per ml and saline, respectively, were added to equal volumes of saline containing approximately 101 ID60 of virus per ml and the mixtures were allowed to stand at room temperature for 2 to 3 hours. Serial decimal dilutions of each of these were inoculated intranasally into groups of 10 mice each, and all survivng mice were sacrificed on the tenth day after inoculation. The infectivity titers of the control and treated virus were practically identical, i.e., 10a6-nd 10", respectively.
Combined action of xerosin with chlortetracycline (aureomycin), oxytetracycline (terramycin), and chloramphenicol (chloromycetin). Figure 3 Efforts to demonstrate antiviral activity of xerosin against influenza B virus in embryonated eggs yielded essentially negative results. Aqueous solutions4 of xerosin containing 2.5 or 5.0 mg per ml and saline, respectively, were mixed in vitro with serial decimal dilutions of influenza B virus and allowed to stand for two hours at room temperature before inoculation into groups of 6 'All solutions of xerosin to be injected into eggs were sterilized with liquid ethylene oxide according to the method of Wilson and Bruno (1950) .
GROUPS, PUGH, LEVINE, AND HERRMANN, JR. eggs each. Allantoic fluid was collected from each egg after 48 hours of incubation at 36 C and tested for the presence or absence of viral hemagglutinin using the pattern test (Salk, 1948 Modification of the neurotoxic effect of influenza A virus. Henle and Henle (1946a) have shown that inoculation of large amounts of the influenza viruses intracerebrally or intravenously into mice resulted in death of the mice in the absence of viral multiplication and that the toxicity of the inocula could not be separated from the virus particle. Later, Schlesinger (1950) reported that the viral hemagglutinin content of brain tissue increased following intracerebral inoculation of large quantities of influenza A virus while the infective titer of the same tissue decreased. He suggested that this phenomenon might be the result of an "incomplete" cycle of viral multiplication. Recently, Frankel and Schlesinger (personal communication, 1952) found that single daily injections of xerosin subcutaneously reduced mortality in mice inoculated intracerebrally with toxic quantities of influenza A virus but did not affect the viral hemagglutinin content of brain tissue. The following eAperiment confirms their observation. One hundred and twenty mice weighing 10 to 12 g each were inoculated intracerebrally with 0.03 ml of undiluted allantoic fluid and divided into 6 groups of 20 mice each. One group received no further treatment. The remaining groups received single daily injections of 1.0 mg of xerosin or 1.0 ml of saline, respectively, beginning one hour after inoculation and according to the schedule shown in table 3. All mice were handled in an identical manner during subcutaneous injection and were disturbed as little as possible. It will be recalled (Henle and Henle, 1946a ) that twirling of mice inoculated with toxic quantities of virus resulted in severe convulsions often followed by death. The data indicate that single daily injections of saline resulted in a higher mortality. However, it is clear from the data presented that mortality was reduced markedly by subcutaneous injection of xerosin and that the effectiveness of xerosin was increased when at least one additional injection was administered on the first day after inoculation of virus.
That contact with xerosin in vitro did not affect the toxicity of influenza A virus for mice by the intracerebral route was shown in the following experiment. An aqueous solution containing 10.0 mg of xerosin per ml was diluted X, 4o, and Xo in infected allantoic fluid containing approximately 1 to 2 LD50 per 0.03 ml. After contact for two hours at room temperature, 0.03 ml amounts of the various mixtures were inoculated intracerebrally into groups of twenty 9 to 11 g mice each. One-half of each group was separated, and the mice were suspended by their tails and twirled twice daily to induce convulsions. The remaining half were left undisturbed. (Sugg, 1950; Ginsberg and Horsfall, 1952) as well as with pneumonia virus of mice (Horsfall and Ginsberg, 1951) have indicated that factors other than viral multiplication are involved in the production of lesions. The nontransmissible pneumonia induced by Newcastle disease virus has been studied extensively by Ginsberg (1951) and by Davenport (1952 (Ginsberg, 1951) and with the neurotoxicity of the influenza viruses for mice (Wagner, 1952) . Further, previous immunization of the host did not affect either the pneumotoxicity of Newcastle disae virus (Davenport, 1952) or the neurotoxicity of influenza A virus (Wagner, 1952) although the toxicity of both viruses was neutralized readily in vitro by their respective antisera. Davenport (1952) has postulated that cell injury may result from either the synthesis or the introduction of sufficient infective virus to exceed the level tolerated by the cell, and that the virus or its degradation products may combine with certain cellular constituents, thus creating cellular imbalance leading to hypertrophy, hyperplasia, or necrosis of the cell. As previously suggested (Groupe et al., 1953) It has been suggested (Davenport, 1952) that useful chemotherapeutic agents for viral diseases may not be limited to those which inhibit viral multiplication, and that a method by which disassociation of cellular components from virus particles or their degradation products may prove to be helpful in achieving effective therapy. The data available on the mechanism of action of xerosin support this suggestion.
SUMIRY
The development of pneumonia in mice following infection with mouse pneumonitis virus (Miyagawanella bronchopneumoniae) and influenza B virus was suppressed by daily parenteral injections of the microbial product, xerosin (formerly designated APM). Xerosin failed to affect viral synthesis in vivo and did not possess antiviral properties in vitro.
Administration of xerosin in concert with chlortetracycline (aureomycin), oxytetracycline (terramycin), and chloramphenicol (chloromycetin) enhanced the therapeutic effectiveness of the last 3 agents. Mortality following intracerebral but not intravenous inoculation of toxic doses of influenza A virus was reduced by parenteral administration of xerosin. The toxicity of influenza A virus for mice was not altered by contact in vitro with xerosin.
The suggestion that substances other than those affecting viral multiplication may prove to be helpful in achieving effective therapy of viral diseases is supported by the data available on xerosm.
